Vivos Therapeutics (VVOS) Change in Account Payables (2020 - 2026)
Vivos Therapeutics (VVOS) reported Change in Account Payables of $318000.0 for Q1 2026, up 191.74% year-over-year from $109000.0 in Q1 2025, and up 175.0% quarter-over-quarter from -$424000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Change in Account Payables (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Change in Account Payables data on file, last reported at $318000.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $318000.0, up 191.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $733000.0 (up 156.69% YoY), and the FY2025 annual result was $524000.0, up 150.0% from the prior year.
- Change in Account Payables advanced to $318000.0 in Q1 2026 per VVOS's latest filing, from -$424000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $767000.0 in Q4 2022 and troughed at -$953000.0 in Q3 2024.
- A 5-year average of $59941.2 and a median of $109000.0 in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables soared 321.43% in 2024, then plunged 2027.27% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $767000.0 in 2022, then decreased by 19.69% to $616000.0 in 2023, then sank by 96.43% to $22000.0 in 2024, then sank by 2027.27% to -$424000.0 in 2025, then surged by 175.0% to $318000.0 in 2026.
- Business Quant data shows VVOS's Change in Account Payables at $318000.0 in Q1 2026, -$424000.0 in Q4 2025, and $340000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | 318,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318,000.00 |
| Mar 31, 2026 | 318,000.00 |
| Dec 31, 2025 | -424,000.00 |
| Dec 31, 2025 | -424,000.00 |
| Sep 30, 2025 | 340,000.00 |
| Sep 30, 2025 | 340,000.00 |
| Jun 30, 2025 | 499,000.00 |
| Jun 30, 2025 | 499,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | -953,000.00 |
| Sep 30, 2024 | -953,000.00 |
| Jun 30, 2024 | -471,000.00 |
| Jun 30, 2024 | -471,000.00 |
| Mar 31, 2024 | 354,000.00 |
| Mar 31, 2024 | 354,000.00 |
| Dec 31, 2023 | 616,000.00 |
| Dec 31, 2023 | 616,000.00 |